MedPath

MCM Vaccines B.V.

Ownership
Private
Employees
-
Market Cap
-
Website

Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)

Phase 3
Completed
Conditions
Hepatitis B
Pertussis
Interventions
Other: Blood Sample
First Posted Date
2016-05-03
Last Posted Date
2020-06-09
Lead Sponsor
MCM Vaccines B.V.
Target Recruit Count
754
Registration Number
NCT02759354

Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)

Phase 3
Completed
Conditions
Bacterial Infections
Virus Diseases
Neisseria Meningitidis
Interventions
Biological: PR5I
Biological: Pediacel®
Biological: NeisVac-C®
Biological: RotaTeq®
Biological: Prevenar 13®
First Posted Date
2013-04-24
Last Posted Date
2019-02-25
Lead Sponsor
MCM Vaccines B.V.
Target Recruit Count
385
Registration Number
NCT01839188

Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)

Phase 3
Completed
Conditions
Neisseria Meningitidis
Bacterial Infections
Virus Diseases
Interventions
Biological: V419
Biological: PREVNAR 13®
Biological: MCC-TT
Biological: MCC-CRM
Biological: Hib-MCC
Biological: MMR Vaccine
First Posted Date
2012-03-14
Last Posted Date
2019-03-28
Lead Sponsor
MCM Vaccines B.V.
Target Recruit Count
284
Registration Number
NCT01553279

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)

Phase 3
Completed
Conditions
Bacterial Infections
Virus Diseases
Interventions
Biological: PR5I
Biological: Rotavirus vaccine
Biological: Prevenar 13™
Biological: INFANRIX™ hexa
First Posted Date
2011-11-28
Last Posted Date
2019-04-02
Lead Sponsor
MCM Vaccines B.V.
Target Recruit Count
1315
Registration Number
NCT01480258

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Phase 3
Completed
Conditions
Virus Diseases
Bacterial Infections
Interventions
Biological: INFANRIX™ hexa
Biological: V419
Biological: RotaTeq
Biological: Prevenar 13
Biological: ProQuad™
First Posted Date
2011-04-26
Last Posted Date
2019-04-30
Lead Sponsor
MCM Vaccines B.V.
Target Recruit Count
1250
Registration Number
NCT01341639
© Copyright 2025. All Rights Reserved by MedPath